Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Pharmaceutical manufacturers can sue competitors for market exclusivity for an orphan drug. This was the outcome of a decision by Munich Regional Court in the dispute between Alexion and Amgen over
designed to protect drug-related patents. For instance, it provides a legal basis for the early settlement of disputes over pharmaceutical patents, allowing patent holders and those seeking market
The German pharmaceutical company Boehringer Ingelheim sought to pre-emptively prohibit Zentiva from selling generic versions of its respiratory drug Ofev. However, UPC judges saw no grounds for
infringes a patent held by Fresenius Kabi, thus overturning a first-instance decision. Fresenius Kabi alleges that Biogen’s Imraldi has infringed its EP 3 145 488 B1 for a ‘liquid pharmaceutical
total 1 pages, 4 items
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
